Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600311 | 12660031 | 1 | I | 201606 | 20160803 | 20160817 | 20160817 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064598 | BRISTOL MYERS SQUIBB | 59.61 | YR | F | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600311 | 12660031 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
| 126600311 | 12660031 | 2 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 3 | SS | TANZEUM | ALBIGLUTIDE | 1 | Subcutaneous | 30 MG, QWK | GAOH19ADA | 0 | 30 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 126600311 | 12660031 | 4 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 5 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 6 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 8 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 126600311 | 12660031 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126600311 | 12660031 | 1 | Product used for unknown indication |
| 126600311 | 12660031 | 2 | Product used for unknown indication |
| 126600311 | 12660031 | 3 | Diabetes mellitus |
| 126600311 | 12660031 | 4 | Product used for unknown indication |
| 126600311 | 12660031 | 5 | Product used for unknown indication |
| 126600311 | 12660031 | 6 | Product used for unknown indication |
| 126600311 | 12660031 | 7 | Product used for unknown indication |
| 126600311 | 12660031 | 8 | Product used for unknown indication |
| 126600311 | 12660031 | 9 | Product used for unknown indication |
| 126600311 | 12660031 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126600311 | 12660031 | HO |
| 126600311 | 12660031 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126600311 | 12660031 | Altered state of consciousness | |
| 126600311 | 12660031 | Blood viscosity increased | |
| 126600311 | 12660031 | Cerebral thrombosis | |
| 126600311 | 12660031 | Drug ineffective | |
| 126600311 | 12660031 | Pulmonary thrombosis | |
| 126600311 | 12660031 | Surgery | |
| 126600311 | 12660031 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126600311 | 12660031 | 3 | 2015 | 0 |